Radiotherapy News and Research RSS Feed - Radiotherapy News and Research

Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).
Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Novartis today announced the US Food and Drug Administration has approved Odomzo (sonidegib, formerly LDE225) 200 mg capsules for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy. [More]
York scientists identify how some micro-RNAs can make prostate cancers resistant to radiotherapy

York scientists identify how some micro-RNAs can make prostate cancers resistant to radiotherapy

Scientists at the University of York believe they have identified how some tiny regulatory molecules in cells can make prostate cancers resistant to radiotherapy. [More]
Additional radiation to surrounding lymph nodes provides added benefit to breast cancer patients

Additional radiation to surrounding lymph nodes provides added benefit to breast cancer patients

A study has found no increase in overall survival but a reduction in breast cancer recurrence when additional radiation is given to the lymph nodes as well as the standard treatment of whole-breast irradiation after breast-conserving surgery. [More]
New treatment improves outcome for early FDG-PET-positive patients with stages I/II Hodgkin lymphoma

New treatment improves outcome for early FDG-PET-positive patients with stages I/II Hodgkin lymphoma

Final results of the randomized intergroup EORTC, LYSA (Lymphoma Study Association), FIL (Fondazione Italiana Linfomi) H10 trial presented at the 13th International Conference on Malignant Lymphoma in Lugano, Switzerland, on 19 June 2015 show that early FDG-PET ( 2-deoxy-2[F-18]fluoro-D-glucose positron emission tomography) adapted treatment improves the outcome of early FDG-PET-positive patients with stages I/II Hodgkin lymphoma. [More]
Apogenix signs licensing agreement with CANbridge to commercialize APG101 in China, Macao and Hong Kong

Apogenix signs licensing agreement with CANbridge to commercialize APG101 in China, Macao and Hong Kong

Apogenix, a next generation immuno-oncology company, announced today that it has entered into an exclusive licensing agreement with CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, for the development and commercialization of lead immuno-oncology drug candidate APG101 in China, Macao, and Hong Kong. [More]
Clinical data on TomoTherapy System presented at AAPM 2015

Clinical data on TomoTherapy System presented at AAPM 2015

Accuray Incorporated announced today that studies on the clinical use of the TomoTherapy System continue to demonstrate its mainstream use and the benefits of its gold-standard treatment planning and delivery capabilities. More than 30 studies were presented during poster or oral sessions at the 57th Annual Meeting of the American Association of Physicists in Medicine held in Anaheim, California July 12 – July 16, 2015. [More]
Three European medical centers planning upgrades to Elekta's stereotactic radiosurgery system for the brain

Three European medical centers planning upgrades to Elekta's stereotactic radiosurgery system for the brain

Three foremost medical centers in the United Kingdom and Germany have ordered and are now planning upgrades to Elekta's latest generation stereotactic radiosurgery system for the brain, Leksell Gamma Knife Icon, to provide the most advanced brain radiosurgery treatments for their patients. [More]
KF-SYSCC creates paperless, filmless clinical process in radiation oncology to enhance patient safety

KF-SYSCC creates paperless, filmless clinical process in radiation oncology to enhance patient safety

The Koo Foundation Sun Yat-Sen Cancer Center has established an entirely paperless and filmless clinical process in radiation oncology, designed to enhance patient safety as well as operational efficiency. Using the ARIA oncology information system from Varian Medical Systems, the clinical team has automated essential tasks, built in safety-checks, and centralized patient information for easier access by staff members. [More]
Children with Wilms tumour can now be given less intensive chemotherapy

Children with Wilms tumour can now be given less intensive chemotherapy

CHILDREN with a rare type of cancer called Wilms' tumour who are at low risk of relapsing can now be given less intensive treatment, avoiding a type of chemotherapy that can cause irreversible heart problems in later life. [More]
Indian hospital treats 10,000th patient using RapidArc radiotherapy technology

Indian hospital treats 10,000th patient using RapidArc radiotherapy technology

A three-year-old baby girl with a brain tumor has become the 10,000th patient at Yashoda Hospital in Hyderabad, India to be treated using RapidArc radiotherapy technology from Varian Medical Systems. [More]
Animated video on TV star Rita May's cancer experience launched to improve awareness of radiotherapy treatment

Animated video on TV star Rita May's cancer experience launched to improve awareness of radiotherapy treatment

A SHORT animated video inspired by the real-life experiences of TV star Rita May while she underwent radiotherapy treatment at Weston Park Hospital has been launched to improve awareness of the life-saving treatment. [More]
Oraya IRay Radiotherapy System for AMD treatment receives Silver award at MDEA 2015

Oraya IRay Radiotherapy System for AMD treatment receives Silver award at MDEA 2015

Oraya Therapeutics Inc.and Bridge Design announced today that the Oraya IRay Radiotherapy System has won the Silver award in the radiological and electromechanical devices category of the 18 Annual Medical Design Excellence Awards (MDEA).The winners were announced at a ceremony in New York City at the Jacob Javits Center in conjunction with the MD&M East event. [More]
International study provides evidence of clear link between smoking and risk of prostate cancer

International study provides evidence of clear link between smoking and risk of prostate cancer

Smoking is a known risk factor for the development of various forms of cancer. However, when it comes to the link between smoking and prostate cancer, the findings of previous studies have been contradictory. Now, for the first time, an international study led by MedUni Vienna and Basle University Hospital, has provided evidence of a clear link. [More]
Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

Researchers highlight important factors that impact early-stage breast cancer patients' access to BCT

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT. [More]
Identifying obstructive coronary artery disease in women: an interview with Dr. Ladapo, NYU School of Medicine

Identifying obstructive coronary artery disease in women: an interview with Dr. Ladapo, NYU School of Medicine

A recent study presented at the American College of Cardiology 64th Annual Scientific Meeting evaluated the impact of an age, sex, and gene expression score on clinical decision-making and the rate of further cardiac evaluation in symptomatic female patients suggestive of CAD in the outpatient setting. [More]
Loyola tests new combination treatment for people living with cancer that has spread to spine

Loyola tests new combination treatment for people living with cancer that has spread to spine

Loyola University Medical Center is the first center in the country to enroll patients in a clinical trial of a minimally invasive treatment for patients living with cancer that has spread to the spine. [More]
Varian selected to equip, service HollandPTC in Delft with ProBeam proton therapy system

Varian selected to equip, service HollandPTC in Delft with ProBeam proton therapy system

Varian Medical Systems today announced that it has been selected to equip and service the new multi-room HollandPTC in Delft with the Varian ProBeam proton therapy system. The company will book the equipment part of the order in its fiscal 2015 third quarter. [More]
New article published in Spanish Journal of Pathology highlights a rare case of Hodgkin's lymphoma

New article published in Spanish Journal of Pathology highlights a rare case of Hodgkin's lymphoma

Dr. Jerónimo Forteza, Professor of Pathology and Director of the Valencian Institute of Pathology, Catholic University of Valencia "San Vicente Mártir," recently published an article in the Spanish Journal of Pathology on the case of a patient with Hodgkin's lymphoma. Medicine student Pablo Sánchez Vela performed this diagnostic work under the supervision of Dr. Forteza. [More]
Apatorsen added to first-line chemotherapy benefits metastatic bladder cancer patients

Apatorsen added to first-line chemotherapy benefits metastatic bladder cancer patients

OncoGenex Pharmaceuticals, Inc. announced that results from an exploratory analysis of the Phase 2 Borealis-1 trial showed that metastatic bladder cancer patients with poor prognostic features benefited from apatorsen 600mg added to first-line chemotherapy compared to chemotherapy alone. [More]
DNA Therapeutics to present DT01 phase 1/2a trial results at ASCO 2015

DNA Therapeutics to present DT01 phase 1/2a trial results at ASCO 2015

DNA Therapeutics, a private biopharmaceutical company developing DT01, a first-in-class clinical pan DNA repair inhibitor to treat tumors resistant to conventional treatments, will today present the results of the first-in-man phase 1/2a trial of DT01 in combination with radiation therapy in patients with cutaneous metastatic melanoma. [More]
Advertisement
Advertisement